1. Published

   Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial

   2019nCoV-302 Study Group, Feb 2022, In: Lancet Respiratory Medicine. 10, 2, p. 167-179

   Research output: Contribution to journal › Article › peer-review